1. Comments on final intelligence in late treated patients with phenylketonuria

   • Harvey L. Levy

   COMMENTARY Pages: S149 - S149

2. PREFACE

   • Peter Burgard
   • Reinhild Link
   • Susanne Schweitzer-Krantz

   Pages: S69 - S69

3. Diet and compliance in phenylketonuria

   • Anita MacDonald

   REVIEW Pages: S136 - S141

4. Comments on in vivo proton magnetic resonance spectroscopy in phenylketonuria

   • Roland Kreis

   COMMENTARY Pages: S126 - S128

5. Mutation analysis anticipates dietary requirements in phenylketonuria

   • Fleming Güttler
   • Per Guldberg

   REVIEW Pages: S150 - S153

6. Final intelligence in late treated patients with phenylketonuria

   • Friedrich K. Trefz
   • Sanja Cipcic-Schmidt
   • Richard Koch

   REVIEW Pages: S145 - S148

7. The international collaborative study of maternal phenylketonuria: status report 1998

   • Richard Koch
   • Eva Friedman
   • Felix de la Cruz

   REVIEW Pages: S156 - S160

8. Survey of national guidelines for the treatment of phenylketonuria

   • Susanne Schweitzer-Krantz
   • Peter Burgard

   REVIEW Pages: S70 - S73

9. Summary of the roundtable discussion

   • Peter Burgard
   • Reinhild Link
   • Susanne Schweitzer-Krantz

   SUMMARY Pages: S163 - S168

10. Comments on neuropsychological approaches to treatment policy issues in phenylketonuria

    • Nanke B. A. Stemerdink

    COMMENTARY Pages: S87 - S88

11. Comments on cognition and intelligence in phenylketonuria

    • Susan E. Waisbren

    COMMENTARY Pages: S80 - S81

12. Comments on behaviour in early treated phenylketonuria

    • Josef Weglage

    COMMENTARY Pages: S94 - S95

13. The neurochemistry of phenylketonuria

    • Robert Surtees
    • Nenad Blau

    REVIEW Pages: S109 - S113

14. Comments on patterns of academic achievement among early treated patients with phenylketonuria

    • Monika Tiefenthaler

    COMMENTARY Pages: S100 - S101

15. In vivo proton magnetic resonance spectroscopy in phenylketonuria

    • Harald E. Möller
    • Kurt Ullrich
    • Josef Weglage

    REVIEW Pages: S121 - S125

16. Nutrition, physical growth, and bone density in treated phenylketonuria

    • Hildegard Przyrembel
    • Hans-Joachim Bremer

    REVIEW Pages: S129 - S135

17. Comments on diet and compliance in phenylketonuria

    • Robert O. Fisch

    COMMENTARY Pages: S142 - S144

18. PAH gene mutation analysis in clinical practice – comments on mutation analysis anticipates dietary requirements in phenylketonuria

    • J. Zschocke
    • G. F. Hoffmann

    COMMENTARY Pages: S154 - S155

19. Comments on the international collaborative study of maternal phenylketonuria status report 1998

    • Philip J. Lee

    COMMENTARY Pages: S161 - S162

20. Neuropsychological approaches to treatment policy issues in phenylketonuria

    • Peter Griffiths

    REVIEW Pages: S82 - S86

21. Development of intelligence in early treated phenylketonuria

    • Peter Burgard

    REVIEW Pages: S74 - S79

22. Behaviour in early treated phenylketonuria: a systematic review

    • Isabel Smith
    • Julie Knowles

    REVIEW Pages: S89 - S93

23. Patterns of academic achievement among patients treated early with phenylketonuria

    • Pi-Nian Chang
    • Robert M. Gray
    • Lisa Lehn O'Brien

    REVIEW Pages: S96 - S99

24. The neuropathology of phenylketonuria: human and animal studies

    • Peter R. Huttenlocher

    REVIEW Pages: S102 - S106

25. Comments on the neuropathology of phenylketonuria

    • Charissa A. Dyer

    COMMENTARY Pages: S107 - S108

26. Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities

    • David P. Brenton
    • Joachim Pietz

    REVIEW Pages: S114 - S120